NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
2.660
+0.240 (9.92%)
At close: Jan 22, 2026, 4:00 PM EST
2.610
-0.050 (-1.88%)
After-hours: Jan 22, 2026, 6:46 PM EST
NewcelX Employees
As of December 31, 2024, NewcelX had 15 total employees, including 11 full-time and 4 part-time employees. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,232,679
Market Cap
12.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 15 | 3 | 25.00% | 11 | 4 |
| Dec 31, 2023 | 12 | -19 | -61.29% | 12 | 0 |
| Dec 31, 2022 | 31 | -1 | -3.13% | 31 | 0 |
| Dec 31, 2020 | 32 | - | - | 28 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NCEL News
- 10 days ago - NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression - PRNewsWire
- 17 days ago - NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board - PRNewsWire
- 6 weeks ago - NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China - PRNewsWire
- 2 months ago - NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute - PRNewsWire
- 2 months ago - NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board - PRNewsWire
- 2 months ago - NewcelX CEO Issues Letter to Shareholders - PRNewsWire
- 2 months ago - NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd. - PRNewsWire